ARHGDIB Antikörper
-
- Target Alle ARHGDIB Antikörper anzeigen
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ARHGDIB Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)
- Aufreinigung
- Immunogen affinity purified
- Reinheit
- ≥95 % as determined by SDS-PAGE
- Immunogen
- Rho GDP dissociation inhibitor(GDI) beta
- Isotyp
- IgG
- Top Product
- Discover our top product ARHGDIB Primärantikörper
-
-
- Applikationshinweise
- WB: 1:500-1:2000, IP: 1:500-1:2000 , IHC: 1:20-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Haltbarkeit
- 12 months
-
- Target
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
- Andere Bezeichnung
- ARHGDIB (ARHGDIB Produkte)
- Hintergrund
- Synonyms:ARHGDIB, D4, GDIA2, GDID4, Ly GDI, LYGDI, RAP1GN1, Rho GDI 2, Rho GDI beta, RhoGDI2,D4GDI Background:Regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them(PubMed:8356058, PubMed:7512369). Regulates reorganization of the actin cytoskeleton mediated by Rho family members(PubMed:8262133).
- Molekulargewicht
- 27 kDa
- Gen-ID
- 397
- UniProt
- P52566
- Pathways
- Caspase Kaskade in der Apoptose
-